Xilio Therapeutics
36 hedge funds and large institutions have $18.6M invested in Xilio Therapeutics in 2025 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
3.4% less ownership
Funds ownership: 45.95% → 42.55% (-3.4%)
Holders
36
Holding in Top 10
5
Calls
–
Puts
–
Top Buyers
| 1 | +$102K | |
| 2 | +$88.2K | |
| 3 | +$78.7K | |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$34.8K |
| 5 |
Renaissance Technologies
New York
|
+$34.1K |
Top Sellers
| 1 | -$906K | |
| 2 | -$407K | |
| 3 | -$191K | |
| 4 |
APP
Avantax Planning Partners
Dubuque,
Iowa
|
-$96.8K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$34.3K |
